Thurston Springer Miller Herd & Titak’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17
Closed -$1.05K 1397
2025
Q4
$1.05K Buy
+17
New +$1.04K ﹤0.01% 1284
2025
Q3
Sell
-124
Closed -$9.9K 1120
2025
Q2
$9.9K Hold
124
﹤0.01% 1145
2025
Q1
$10.7K Buy
+124
New +$10.2K ﹤0.01% 1095

Other funds holding PBH

Thurston Springer Miller Herd & Titak's PBH Position: Q1 2026 in Review

Thurston Springer Miller Herd & Titak sold out of Prestige Consumer Healthcare (PBH) in Q1 2026, closing a stake of 17 shares — an estimated $1.05K sold.

Thurston Springer Miller Herd & Titak first reported a position in PBH in Q1 2025 and held it in 3 quarters. The position peaked at $10.7K in Q1 2025. 355 funds tracked by Wall St. Rank hold PBH as of Q1 2026.

  • Thurston Springer Miller Herd & Titak reported no remaining Prestige Consumer Healthcare position as of Q1 2026 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 17 Prestige Consumer Healthcare shares in Q1 2026, an estimated $1.05K.
  • Thurston Springer Miller Herd & Titak first reported a position in Prestige Consumer Healthcare in Q1 2025 and held it in 3 quarters.
  • Thurston Springer Miller Herd & Titak's Prestige Consumer Healthcare position peaked at $10.7K in Q1 2025.
  • 355 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q1 2026, filed 14 Apr 2026.